NCT04308759View on ClinicalTrials.gov

An Innovative Conversational Agent (Quitbot) for Smoking Cessation

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,647

Participants

Timeline

Start Date

July 24, 2022

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2026

Conditions
Cigarette Smoking-Related Carcinoma
Interventions
OTHER

Experimental Smoking Cessation Program

Participate in Quitbot experimental cessation program

OTHER

Control Smoking Cessation Program

Participate in Quitbot control cessation program

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER